3-Aminopiperidine-2,6-dione hydrobromide is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those with potential therapeutic applications. The compound is often employed in the creation of small molecule inhibitors and modulators that target specific enzymes or receptors involved in disease pathways. Its structural features make it a valuable building block for designing molecules with enhanced pharmacokinetic properties. Additionally, it is explored in the development of anticancer agents, as its derivatives have shown promise in inhibiting tumor growth and inducing apoptosis in cancer cells. The hydrobromide salt form enhances its stability and solubility, facilitating its use in experimental formulations and drug delivery systems.